Teva Can Market Generic Provigil Three Years Before Patent Expiration

Under a settlement with Cephalon, Teva’s modafinil can enter the market in 2011 or 2012, depending on a potential pediatric extension.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet